Tavros Therapeutics.

PositionTRIANGLE: DURHAM

Oncology startup Tavros Therapeutics signed a five-year agreement with San Diego-based Vividion Therapeutics that could bring as much as $430.5 million to the local firm over the next five years. Tavros...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT